DS-Cav1 RSV F subunit vaccine (VRC-RSVRGP084-00-VP)

RSV F subunit vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-Cav1 RSV F subunit vaccine (VRC-RSVRGP084-00-VP), covering 2020-10-23 to 2020-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults [Phase 1]

See pricing